PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
Position in MDXG — Mimedx Group, Inc.
CIK 1238990
EDINA, MN
Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,923,642
-$54,244 QoQ
Shares Held
2,058,089
+1.9% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#12
of 226 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. holds $41,450,025 across 2 Biotechnology names. MDXG ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
597,938 | $33,526,383 | |
| 2 | MDXG |
Mimedx Group, Inc.
This page
|
2,058,089 | $7,923,642 |
All Filings in MDXG
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,923,642 | 2,058,089 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,977,886 | 2,019,718 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,588,703 | 2,007,194 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,994,997 | 2,005,014 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,060,724 | 1,973,932 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,213,952 | 1,738,678 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,606,659 | 1,726,264 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,327,866 | 1,747,524 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,963,221 | 1,149,094 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,806,186 | 624,180 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||